20/20 GeneSystems Campaign's Highlights
Diagnostic Testing for COVID-19 & Cancer
- Huge Market - The global cancer diagnostics market was valued at $7.1 billion in 2015 and is projected to reach $13.1 billion by the year 2020
- Experienced Team - Our CEO previously established strategic partnerships with Fortune 500 companies such as Johnson & Johnson, Eastman Kodak, Abbott Diagnostics and Smiths Detection
- Traction - We're backed by China’s Ping An Ventures, likely the world’s largest Healthcare AI company (300 million users of its mobile diagnostic app) & thousands of investors
Did I Invest In 20/20 GeneSystems?
I’m still in the process of writing a full deal report and decide whether or not I will invest in 20/20 GeneSystems. I review 100+ startups on 10+ platforms every month and send a detailed report every Saturday to subscribers of the Angel Notes newsletter (you can join through the form below). See you soon!